The Effects of Tualang Honey on Bone Metabolism of Postmenopausal Women

Abstract EN

Osteoporosis which is characterized by low bone mass and microarchitectural deterioration with a consequent increase in bone fragility can be associated with various stimuli such as oxidative stress and inflammation.

Postmenopausal women are more prone to osteoporosis due to reduction in estrogen which may further lead to elevation of oxidative stress and lipid accumulation which will promote osteoblasts apoptosis.

Proinflammatory cytokines are elevated following estrogen deficiency.

These cytokines are important determinants of osteoclasts differentiation and its bone resorption activity.

The main treatment for postmenopausal osteoporosis is estrogen replacement therapy (ERT).

Despite its effectiveness, ERT, however, can cause many adverse effects.

Therefore, alternative treatment that is rich in antioxidant and can exert an anti-inflammatory effect can be given to replace the conventional ERT.

Tualang honey is one of the best options available as it contains antioxidant as well as exerting anti-inflammatory effect which can act as a free radical scavenger, reducing the oxidative stress level as well as inhibiting proinflammatory cytokine.

This will result in survival of osteoblasts, reduced osteoclastogenic activity, and consequently, reduce bone loss.

Hence, Tualang honey can be used as an alternative treatment of postmenopausal osteoporosis with minimal side effects.